CURE Epilepsy Catalyst Award
The purpose of this funding opportunity is to stimulate and accelerate discovery and development of new, transformative therapies for epilepsy, moving promising, well-supported preclinical and/or clinical research closer to clinical application. Projects based on novel biological pathways and/or highly differentiated therapeutic approaches which are likely to have a high probability of successfully transitioning to clinical development are strongly encouraged. The award is not intended to fund basic research on the mechanisms underlying epilepsy. Proof-of-concept data is required.
This award is available to independent researchers at or above the level of Assistant Professor (or equivalent) at universities and non-academic research institutions, including small biotechnology companies, that seek to develop new interventions for epilepsy. International applicants are welcome to apply. Postdoctoral fellows may not apply for this award. All materials must be submitted in English.
- Open Call for Letters of Intent due Tuesday, May 31, 2022
- Letter of Intent Deadline due Wednesday, June 29, 2022, 9PM ET
- Full Proposal Invitations due Friday, August 5, 2022
- Full Proposals due Tuesday, September 13, 2022, 9PM ET
- Awardee Notification due December 2022-January 2023
- Anticipated Award Start Date Spring 2023
Please refer to the Request for Proposals for an overview of the priority areas, application instructions, and FAQs.
Reach out to the CURE Epilepsy research team at Research@CUREEpilepsy.org with any questions you may have.
Research Supplements to Promote Diversity in Health-Related Research
Diversity supplements are additional NIH funds awarded to an existing parent grant providing full salary (plus expenses for supplies/travel) to support individuals from historically marginalized groups. The IDDRC is committed to increasing diversity among its centers and would like to encourage its members to apply for this awarding mechanism. Even if you do not have a current active grant (or yours is ineligible), we can still apply using the IDDRC P50 as the parent grant. Eligible candidates include those from underrepresented ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds.
Our goal is to have at least one application in the first year and a funded supplement every year afterwards (but we feel we can do better than this!). To help with this goal, Dr. Noguchi has created a presentation outlining candidate eligibility, supplement requirements, and how to apply. If you, or someone you know, might be interested in applying please contact us. We can: 1) answer any questions, 2) provide you with previous successful applications, and 3) help connect candidates and PIs with each other. We would also like to hear from you if you plan on applying or already have a Diversity supplement so we can track progress.
If you have any questions or would like to notify us of an application please contact Dr. Noguchi:
Kevin Noguchi, Ph.D.
Assistant Professor of Psychiatry
Washington University in St. Louis
School of Medicine
Department of Psychiatry
4523 Clayton Avenue, #8134
St. Louis, MO 63110